Cite
HARVARD Citation
Sahin, I. et al. (2021). Regorafenib, an investigational agent for the treatment of cholangiocarcinoma. Expert opinion on investigational drugs. pp. 333-341. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sahin, I. et al. (2021). Regorafenib, an investigational agent for the treatment of cholangiocarcinoma. Expert opinion on investigational drugs. pp. 333-341. [Online].